Brii Bio­sciences stops man­u­fac­tur­ing Covid-19 an­ti­body com­bo, plans to with­draw EUA re­quest

Brii Bio­sciences said it will stop man­u­fac­tur­ing its Covid-19 an­ti­body com­bi­na­tion, sold in Chi­na, and is work­ing to with­draw its emer­gency use au­tho­riza­tion re­quest in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER